Research article: Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
A new VANGUARD research article on Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device has been published in Molecular Therapy, Methods & Clinical Development. The full article can be read online: https://doi.org/10.1016/j.omtm.2021.10.015 Abstract: Hemophilia A (HA) is a rare bleeding disorder caused by deficiency/dysfunction of the FVIII protein. […]
